The Pro-Longevity Gene Foxo3 Is a Direct Target of the P53 Tumor Suppressor

Total Page:16

File Type:pdf, Size:1020Kb

The Pro-Longevity Gene Foxo3 Is a Direct Target of the P53 Tumor Suppressor Oncogene (2011) 1–15 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor VM Renault1, PU Thekkat1, KL Hoang1, JL White1, CA Brady2,3, D Kenzelmann Broz2, OS Venturelli1, TM Johnson2,3, PR Oskoui1, Z Xuan4, EE Santo5, MQ Zhang4,6, H Vogel7, LD Attardi1,2,3 and A Brunet1,3 1Department of Genetics, Stanford University, Stanford, CA, USA; 2Department of Radiation Oncology, Stanford University, Stanford, CA, USA; 3Cancer Biology Graduate Program, Stanford University, Stanford, CA, USA; 4Department of Molecular and Cell Biology, Center for Systems Biology, University of Texas at Dallas, Richardson, TX, USA; 5Department of Human Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 6MOE Key Laboratory of Bioinformatics & Bioinformatics Division, TNLIS, Tsinghua University, Beijing, China and 7Department of Pathology, Stanford University, Stanford, CA, USA FoxO transcription factors have a conserved role in 2005). The connection between aging and cancer raises longevity, and act as tissue-specific tumor suppressors the possibility that genes that extend lifespan may also in mammals. Several nodes of interaction have been be part of a molecular network that suppresses identified between FoxO transcription factors and p53, a tumorigenesis. An example for such genes is provided major tumor suppressor in humans and mice. However, by FoxO transcription factors, which have a pivotal role the extent and importance of the functional interaction at the interface between longevity and tumor suppres- between FoxO and p53 have not been fully explored. sion (Greer and Brunet, 2005). In invertebrates, FoxO Here, we show that p53 regulates the expression of factors are necessary to extend lifespan downstream of FoxO3, one of the four mammalian FoxO genes, in the insulin pathway (Kenyon, 2005). In mammals, the response to DNA damaging agents in both mouse four FoxO family members (FoxO1, FoxO3, FoxO4 embryonic fibroblasts and thymocytes. We find that p53 and FoxO6) also function downstream of the insulin- transactivates FoxO3 in cells by binding to a site in the signaling pathway (Greer and Brunet, 2005). Single- second intron of the FoxO3 gene, a genomic region nucleotide polymorphisms in the FoxO3 gene have recently found to be associated with extreme longevity in recently been found to be associated with extreme humans. While FoxO3 is not necessary for p53-dependent longevity in humans, suggesting a conserved function cell cycle arrest, FoxO3 appears to modulate p53- for FoxO3 in longevity (Willcox et al., 2008; Anselmi dependent apoptosis. We also find that FoxO3 loss does et al., 2009; Flachsbart et al., 2009; Pawlikowska et al., not interact with p53 loss for tumor development in vivo, 2009). Interestingly, the FoxO family has also been although the tumor spectrum of p53-deficient mice appears found to act as a lineage-specific tumor suppressor in to be affected by FoxO3 loss. Our findings indicate that mammals (Paik et al., 2007). Combined somatic deletion FoxO3 is a p53 target gene, and suggest that FoxO3 and of FoxO1, FoxO3 and FoxO4 in mice leads to the p53 are part of a regulatory transcriptional network that development of tumors, particularly thymic lymphomas may have an important role during aging and cancer. and hemangiomas (Paik et al., 2007). FoxO3À/À mice can Oncogene advance online publication, 21 March 2011; also develop cancer, but at a lesser frequency and later doi:10.1038/onc.2011.35 in life than FoxO1/FoxO3/FoxO4 compound mutant mice (Paik et al., 2007). In humans, FoxO3 inactivation Keywords: FoxO transcription factors; p53; tumor is correlated with poor prognosis of breast cancers (Hu suppression; cancer; aging; longevity et al., 2004). Conversely, ectopic expression of FoxO3 in human cells is sufficient to delay tumor development in xenograft models (Hu et al., 2004; Seoane et al., 2004). Thus, FoxO3 may be an important part of a regulatory Introduction network that controls both aging and cancer. FoxO3 is a potent transcriptional activator that Aging and cancer are intimately linked. Many cancers triggers the expression of a program of genes involved have a striking age-dependent onset. Interventions that in cell cycle arrest, DNA repair, hypoxia response and extend lifespan, such as dietary restriction, decrease the apoptosis (Brunet et al., 1999; Medema et al., 2000; incidence of tumors (Hursting et al., 2003; Masoro, Tran et al., 2002; Seoane et al., 2004; You et al., 2006a; Bakker et al., 2007; Tothova et al., 2007; Paik et al., 2009; Renault et al., 2009). FoxO3 transcriptional Correspondence: Dr A Brunet, Department of Genetics, Stanford activity is inhibited in response to insulin and growth University, 300 Pasteur Drive, Alway M336, Stanford, CA 94305, USA. factors through phosphorylation-dependent nuclear E-mail: [email protected] export (Brunet et al., 1999, 2001, 2002). Although the Received 20 December 2010; accepted 18 January 2011 regulation of FoxO3 activity by post-translational FoxO3 is a direct target of p53 VM Renault et al 2 modifications, such as phosphorylation, has been well interaction between FoxO3 and p53 loss in cancer studied (Van Der Heide et al., 2004; Calnan and Brunet, progression in the absence of oncogenic stimulation 2008), the molecular mechanisms that regulate the has never been tested. expression of the FoxO3 gene remain mostly unclear. Here, we explore the connections between FoxO3, a Given the connection between aging and cancer, it is ubiquitously expressed FoxO family member, and p53 in interesting to note that there are a number of parallels cells and in mice. We find that p53 acts as a direct between FoxO3 and the tumor suppressor protein p53. upstream transcriptional activator of the FoxO3 gene in Like FoxO3, p53 induces cell cycle arrest, apoptosis and response to DNA damage in mouse embryonic fibro- DNA repair (Vousden and Lu, 2002). Several FoxO3 blasts (MEFs) and in lymphocytes. We show that p53 target genes, such as Gadd45, Wip1, p21Cip1, Puma and regulates the transcription of the FoxO3 gene by binding Sestrin1/PA26, are also regulated by p53 (Kastan et al., to a site in the second intron of the FoxO3 gene. 1992; el-Deiry et al., 1993; Fiscella et al., 1997; Velasco- Although FoxO3 is not necessary for p53-dependent Miguel et al., 1999; Nakano and Vousden, 2001; Yu cell cycle arrest, FoxO3 appears to have a role in et al., 2001). FoxO3 and p53 are extensively modified in p53-dependent apoptosis. While FoxO3 loss does not response to stress stimuli, through phosphorylation synergize with p53 loss for tumor development in vivo, and acetylation (Calnan and Brunet, 2008; Vousden tumor spectrum in p53-deficient mice appears to be and Prives, 2009), and both p53 and FoxO3 bind to and affected by the loss of one or both FoxO3 alleles. These are deacetylated by the Sirt1 deacetylase (Luo et al., results reveal a regulatory mechanism linking FoxO3 2001; Vaziri et al., 2001; Brunet et al., 2004; Motta et al., and p53, two critical molecules involved in the control of 2004). These extensive similarities between FoxO3 and longevity and tumor suppression. p53 suggest that both transcription factors may be part of a common regulatory complex. A number of direct and indirect links between FoxO3 and p53 have already been uncovered. First, FoxO3 Results directly binds to p53, at least in the context of overexpression (Nemoto et al., 2004; Wang et al., DNA damage and nutlin treatment increase FoxO3 2008). Second, FoxO3 leads to stabilization of the p53 protein levels in a p53-dependent manner in fibroblasts protein and activation of p53-dependent apoptosis To test whether p53 regulates FoxO3 expression in (You et al., 2006b). FoxO3 also upregulates p19ARF,a mammalian cells, we compared FoxO3 protein levels in þ / þ À/À positive upstream regulator of p53 (Bouchard et al., p53 and p53 primary MEFs in the absence or 2007). Conversely, p53 has been reported to inhibit presence of doxorubicin, a DNA damaging agent that FoxO3 function indirectly by upregulating serum- and activates endogenous p53. We found that doxorubicin þ / þ glucocorticoid-induced protein kinase (SGK), thereby treatment increased FoxO3 protein expression in p53 MEFs, but not in p53À/À MEFs (Figure 1a). Changes in resulting in the phosphorylation of FoxO3 and its Cip1 sequestration in the cytoplasm (You et al., 2004). In FoxO3 protein levels were similar to those of p21 ,a addition, p53 has been found to inhibit FoxO3 well-known target of p53 (Figure 1a). To activate p53 transcriptional activity under conditions of oxidative in a more specific manner, we used nutlin, a chemical stress (Miyaguchi et al., 2009) and to induce FoxO3 compound that inhibits binding of p53 to Mdm2, a degradation (Fu et al., 2009). Whether FoxO3 and p53 intersect in other ways, for example by regulating each other’s transcription, remains largely unknown. p53+/+ p53-/- p53+/+ p53-/- p53 is a potent tumor suppressor in humans, as Dox: - + - + Nutlin Dox Nutlin Dox underscored by the fact that nearly all human tumors hr: 0 4848 04848 have mutations or deletions in the p53 gene itself or in FoxO3 the p53 pathway (Vogelstein et al., 2000). Mutations in FoxO3 p53 have been linked to poor prognosis in a variety of p21Cip1 human cancers, including lung (Quinlan et al., 1992), p53 breast (Deng et al., 1994) and gastric cancers (Scott p53 et al., 1991), as well as lymphomas (Gaidano et al., 1991; β-actin Lo Coco et al., 1993). Consistent with the prevalence of p53 loss in human tumors, p53À/À mice are highly prone Mek1 to cancer early in life (Donehower et al., 1992; Harvey et al., 1993a, 1993b; Jacks et al., 1994). p53 þ /À mice also Figure 1 Doxorubicin and nutlin elicit an increase in FoxO3 protein develop tumors with high frequency (Donehower et al., expression that is p53-dependent in MEFs.
Recommended publications
  • Forkhead Transcription Factors and Ageing
    Oncogene (2008) 27, 2351–2363 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc REVIEW Forkhead transcription factors and ageing L Partridge1 and JC Bru¨ ning2 1Institute of Healthy Ageing, GEE, London, UK; 2Department of Mouse Genetics and Metabolism, Institute for Genetics University of Cologne, Cologne, Germany Mutations in single genes and environmental interventions Forkhead transcription factors are turning out to play can extend healthy lifespan in laboratory model organi- a key role in invertebrate models ofextension ofhealthy sms. Some of the mechanisms involved show evolutionary lifespan by single-gene mutations, and evidence is conservation, opening the way to using simpler inverte- mounting for their importance in mammals. Forkheads brates to understand human ageing. Forkhead transcrip- can also play a role in extension oflifespanby dietary tion factors have been found to play a key role in lifespan restriction, an environmental intervention that also extension by alterations in the insulin/IGF pathway and extends lifespan in diverse organisms (Kennedy et al., by dietary restriction. Interventions that extend lifespan 2007). Here, we discuss these findings and their have also been found to delay or ameliorate the impact of implications. The forkhead family of transcription ageing-related pathology and disease, including cancer. factors is characterized by a type of DNA-binding Understanding the mode of action of forkheads in this domain known as the forkhead box (FOX) (Weigel and context will illuminate the mechanisms by which ageing Jackle, 1990). They are also called winged helix acts as a risk factor for ageing-related disease, and could transcription factors because of the crystal structure lead to the development of a broad-spectrum, preventative ofthe FOX, ofwhich the forkheadscontain a medicine for the diseases of ageing.
    [Show full text]
  • World Population Ageing 2019
    World Population Ageing 2019 Highlights ST/ESA/SER.A/430 Department of Economic and Social Affairs Population Division World Population Ageing 2019 Highlights United Nations New York, 2019 The Department of Economic and Social Affairs of the United Nations Secretariat is a vital interface between global policies in the economic, social and environmental spheres and national action. The Department works in three main interlinked areas: (i) it compiles, generates and analyses a wide range of economic, social and environmental data and information on which States Members of the United Nations draw to review common problems and take stock of policy options; (ii) it facilitates the negotiations of Member States in many intergovernmental bodies on joint courses of action to address ongoing or emerging global challenges; and (iii) it advises interested Governments on the ways and means of translating policy frameworks developed in United Nations conferences and summits into programmes at the country level and, through technical assistance, helps build national capacities. The Population Division of the Department of Economic and Social Affairs provides the international community with timely and accessible population data and analysis of population trends and development outcomes for all countries and areas of the world. To this end, the Division undertakes regular studies of population size and characteristics and of all three components of population change (fertility, mortality and migration). Founded in 1946, the Population Division provides substantive support on population and development issues to the United Nations General Assembly, the Economic and Social Council and the Commission on Population and Development. It also leads or participates in various interagency coordination mechanisms of the United Nations system.
    [Show full text]
  • Dissecting Aging and Senescence—Current Concepts and Open Lessons
    cells Review Dissecting Aging and Senescence—Current Concepts and Open Lessons 1,2, , 1,2, 1 1,2 Christian Schmeer * y , Alexandra Kretz y, Diane Wengerodt , Milan Stojiljkovic and Otto W. Witte 1,2 1 Hans-Berger Department of Neurology, Jena University Hospital, 07747 Jena, Thuringia, Germany; [email protected] (A.K.); [email protected] (D.W.); [email protected] (M.S.); [email protected] (O.W.W.) 2 Jena Center for Healthy Ageing, Jena University Hospital, 07747 Jena, Thuringia, Germany * Correspondence: [email protected] These authors have contributed equally. y Received: 2 October 2019; Accepted: 13 November 2019; Published: 15 November 2019 Abstract: In contrast to the programmed nature of development, it is still a matter of debate whether aging is an adaptive and regulated process, or merely a consequence arising from a stochastic accumulation of harmful events that culminate in a global state of reduced fitness, risk for disease acquisition, and death. Similarly unanswered are the questions of whether aging is reversible and can be turned into rejuvenation as well as how aging is distinguishable from and influenced by cellular senescence. With the discovery of beneficial aspects of cellular senescence and evidence of senescence being not limited to replicative cellular states, a redefinition of our comprehension of aging and senescence appears scientifically overdue. Here, we provide a factor-based comparison of current knowledge on aging and senescence, which we converge on four suggested concepts, thereby implementing the newly emerging cellular and molecular aspects of geroconversion and amitosenescence, and the signatures of a genetic state termed genosenium.
    [Show full text]
  • Mechanisms and Rejuvenation Strategies for Aged Hematopoietic
    Li et al. Journal of Hematology & Oncology (2020) 13:31 https://doi.org/10.1186/s13045-020-00864-8 REVIEW Open Access Mechanisms and rejuvenation strategies for aged hematopoietic stem cells Xia Li1,2,3†, Xiangjun Zeng1,2,3†, Yulin Xu1,2,3, Binsheng Wang1,2,3, Yanmin Zhao1,2,3, Xiaoyu Lai1,2,3, Pengxu Qian1,2,3 and He Huang1,2,3* Abstract Hematopoietic stem cell (HSC) aging, which is accompanied by reduced self-renewal ability, impaired homing, myeloid-biased differentiation, and other defects in hematopoietic reconstitution function, is a hot topic in stem cell research. Although the number of HSCs increases with age in both mice and humans, the increase cannot compensate for the defects of aged HSCs. Many studies have been performed from various perspectives to illustrate the potential mechanisms of HSC aging; however, the detailed molecular mechanisms remain unclear, blocking further exploration of aged HSC rejuvenation. To determine how aged HSC defects occur, we provide an overview of differences in the hallmarks, signaling pathways, and epigenetics of young and aged HSCs as well as of the bone marrow niche wherein HSCs reside. Notably, we summarize the very recent studies which dissect HSC aging at the single-cell level. Furthermore, we review the promising strategies for rejuvenating aged HSC functions. Considering that the incidence of many hematological malignancies is strongly associated with age, our HSC aging review delineates the association between functional changes and molecular mechanisms and may have significant clinical relevance. Keywords: Hematopoietic stem cells, Aging, Single-cell sequencing, Epigenetics, Rejuvenation Background in the clinic, donor age is carefully considered in HSC A key step in hematopoietic stem cell (HSC) aging re- transplantation, and young donors result in better sur- search was achieved in 1996, revealing that HSCs from vival after HSC transplantation [2–4].
    [Show full text]
  • 2 the Biology of Ageing
    The biology of ageing 2 Aprimer JOAO˜ PEDRO DE MAGALHAES˜ OVERVIEW .......................................................... This chapter introduces key biological concepts of ageing. First, it defines ageing and presents the main features of human ageing, followed by a consideration of evolutionary models of ageing. Causes of variation in ageing (genetic and dietary) are reviewed, before examining biological theories of the causes of ageing. .......................................................... Introduction Thanks to technological progress in different areas, including biomed- ical breakthroughs in preventing and treating infectious diseases, longevity has been increasing dramatically for decades. The life expectancy at birth in the UK for boys and girls rose, respectively, from 45 and 49 years in 1901 to 75 and 80 in 1999 with similar fig- ures reported for other industrialized nations (see Chapter 1 for further discussion). A direct consequence is a steady increase in the propor- tion of people living to an age where their health and well-being are restricted by ageing. By the year 2050, it is estimated that the per- centage of people in the UK over the age of 65 will rise to over 25 per cent, compared to 14 per cent in 2004 (Smith, 2004). The greying of the population, discussed elsewhere (see Chapter 1), implies major medical and societal changes. Although ageing is no longer considered by health professionals as a direct cause of death (Hayflick, 1994), the major killers in industrialized nations are now age-related diseases like cancer, diseases of the heart and 22 Joao˜ Pedro de Magalhaes˜ neurodegenerative diseases. The study of the biological mechanisms of ageing is thus not merely a topic of scientific curiosity, but a crucial area of research throughout the twenty-first century.
    [Show full text]
  • Oxidative Stress, Cellular Senescence and Ageing Akshaj Pole
    Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Biochemistry and Molecular Medicine Faculty Biochemistry and Molecular Medicine Publications 5-2016 Oxidative stress, cellular senescence and ageing Akshaj Pole Manjari Dimri George Washington University Goberdhan P. Dimri George Washington University Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_biochem_facpubs Part of the Cell and Developmental Biology Commons, and the Molecular Biology Commons APA Citation Pole, A., Dimri, M., & Dimri, G. P. (2016). Oxidative stress, cellular senescence and ageing. AIMS Molecular Science, 3 (3). http://dx.doi.org/10.3934/molsci.2016.3.300 This Journal Article is brought to you for free and open access by the Biochemistry and Molecular Medicine at Health Sciences Research Commons. It has been accepted for inclusion in Biochemistry and Molecular Medicine Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. AIMS Molecular Science, 3(3): 300-324. DOI: 10.3934/molsci.2016.3.300 Received 17 May 2016, Accepted 14 June 2016, Published 17 June 2016 http://www.aimspress.com/journal/Molecular Review Oxidative stress, cellular senescence and ageing Akshaj Pole, Manjari Dimri, and Goberdhan P. Dimri* Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington DC, USA * Correspondence: Email [email protected]; Tel: (202) 994-6112; Fax: (202) 994-8974. Abstract: Almost a half century ago, the free radical theory of ageing proposed that the reactive oxygen species (ROS) is a key component which contributes to the pathophysiology of ageing in mammalian cells.
    [Show full text]
  • The Ageing & Development Report
    The Ageing & Development Report: a summary Poverty, Independence & the World’s Older People The Ageing & Development Report: a summary HelpAge International is a global network of not for profit organisations with a mission to work with and for disadvantaged older people worldwide to achieve a lasting improvement in the quality of their lives. Contents 1 What is The Ageing & Development Report? 2 Ageing societies: The global challenge for the new millennium 4 National development policies to support older people 4 Invisible figures: Why is so little known about older people? 6 Ageing in a changing world 7 Surviving disaster: Older people in humanitarian crises 7 Poverty: The enemy of older people’s independence 9 The economic contribution of older people 10 Different needs, different expectations: Gender roles in older age 12 Life-long deprivation and older people’s health needs 13 Supporting capability: Building state, family and community partnerships 16 Promoting the United Nations Principles for Older Persons The Ageing & Development Report: 1 a summary What is The Ageing & Development Report? The Ageing & Development Report is the first extensive survey of the roles and needs of older people in developing countries. The report examines the major social and economic implications of the rapid growth in numbers of older people in Africa, Asia, the Americas and Russia, Eastern and Central Europe. It covers the impact on economies, health systems, housing, working patterns and family relationships. The report draws on HelpAge International’s 20 years experience in over 60 countries, with contributions from world experts in the field. Key themes, such as community involvement, family life, health and wellbeing, poverty and exclusion, gender, migration and economic security are addressed.
    [Show full text]
  • Aging & Society
    Aging & Society: Seventh Interdisciplinary Conference Social Inequalities, Exclusion, and Age-Discrimination 3–4 NOVEMBER 2017 | UNIVERSITY OF CALIFORNIA AT BERKELEY | BERKELEY, USA AGINGANDSOCIETY.COM Aging & Society: Seventh Interdisciplinary Conference “Social Inequalities, Exclusion, and Age-Discrimination” 3–4 November 2017 | University of California at Berkeley | Berkeley, USA www.agingandsociety.com www.facebook.com/AgingandSociety @agingandsociety | #agingandsociety2017 Aging & Society: Seventh Interdisciplinary Conference www.agingandsociety.com First published in 2017 in Champaign, Illinois, USA by Common Ground Research Networks www.cgnetworks.org © 2017 Common Ground Research Networks All rights reserved. Apart from fair dealing for the purpose of study, research, criticism, or review as permitted under the applicable copyright legislation, no part of this work may be reproduced by any process without written permission from the publisher. For permissions and other inquiries, please contact [email protected]. Common Ground Research Networks may at times take pictures of plenary sessions, presentation rooms, and conference activities which may be used on Common Ground’s various social media sites or websites. By attending this conference, you consent and hereby grant permission to Common Ground to use pictures which may contain your appearance at this event. Designed by Ebony Jackson Cover image by Phillip Kalantzis-Cope Aging & Society agingandsociety.com Dear Aging & Society Delegates, Welcome to Berkeley and to Aging & Society: Seventh Interdisciplinary Conference. The Aging & Society Research Network—its conference, journal, and book imprint—was created to explore the changing social dynamics of aging Founded in 2011, the Aging & Society Research Network is a forum for the discussion of the challenges and opportunities for a rapidly growing segment of the population worldwide.
    [Show full text]
  • What Can Worms Tell Us About Ageing in Humans?
    “The image shows C. elegans growing on an agar plate. The biggest worm in the picture is an adult and is about 1mm long. We have to use microscopes to look at them because xthey are so small. The worms are also transparent, so if you look carefully you can see their eggs inside and the different cells joining together.” Dr Jennifer Tullet WHAT CAN WORMS TELL US ABOUT AGEING IN HUMANS? A NEMATODE WORM CALLED C. ELEGANS HAS A LIFESPAN OF ABOUT THREE WEEKS, SO WHAT CAN IT TELL US ABOUT HOW AND WHY WE , BASED AT THE AGE? BIOGERONTOLOGIST DR JENNIFER TULLET UNIVERSITY OF KENT, IS INVESTIGATING LIFESPAN AND THE AGEING PROCESS USING THESE WORMS. THEIR SIMILARITY TO MAMMALS MEANS THAT THESE STUDIES CAN ALSO BE APPLIED TO HUMANS The concept of ageing has preoccupied minds The results of these studies can be applied IMAGINE THIS for centuries. For example, Qin Shi Huang, to a range of species, including humans, as the first emperor of China (221-206 BC), is Jenny explains: “We share about 70% of our According to the World Health claimed to have consumed cinnabar – a deadly DNA with C. elegans. Many of their genes, Organization, the proportion of the mercury sulphide – in his quest for immortality. cell signalling pathways and the biology that world’s population over 60 years will While the cause of his death might be obvious, they control are the same. This means that we double from about 11% to 22%. Thanks the question as to why we cannot live forever can use C.
    [Show full text]
  • The Search for a Treatment for Ageing (PDF)
    The search for a treatment for ageing OVERVIEW • Geroscience research is exploring and some are already being tested in human interventions that delay biological ageing and clinical trials. reduce the risk of age-related diseases and • Many uncertainties remain about the effects conditions. that treatments for ageing would have • Strong market demand is driving investment on human health span and lifespan, the in geroscience research, particularly in economy, models of care, health inequalities, the US. Investment in this area has been personal identity, and how people work and highlighted as a key opportunity for the UK in live later in life. the future. • There are calls for an ethical framework • Animal research has led to the discovery for geroscience research to help guide of several potential interventions for ageing researchers, policy makers and consumers. INTRODUCTION In most countries, people are living longer and number of older people is predicted to increase healthier lives than ever, but are still spending markedly over the next 25 years,2 addressing a significant number of years in poor health age-related health conditions is a pressing towards the end of their lives.1 Common societal challenge. Healthy ageing is a priority conditions experienced by older people include policy area for the World Health Organization and cardiovascular disease, cancer, dementia, governments around the globe. arthritis, and general frailty. Given that the Geroscience, also called biogerontology, is a we are healthy – than tackling each condition field of research that is exploring the biological individually. This briefing note summarises processes that underlie ageing. Researchers the main scientific developments to date, and working in this field believe that intervening in the potential ethical and social issues that the these processes could be a more efficient way discovery of a treatment for ageing might raise.
    [Show full text]
  • Rejuvenation by Cell Reprogramming: a New Horizon in Gerontology Rodolfo G
    Goya et al. Stem Cell Research & Therapy (2018) 9:349 https://doi.org/10.1186/s13287-018-1075-y REVIEW Open Access Rejuvenation by cell reprogramming: a new horizon in gerontology Rodolfo G. Goya1*† , Marianne Lehmann1†, Priscila Chiavellini1, Martina Canatelli-Mallat1, Claudia B. Hereñú2 and Oscar A. Brown1 Abstract The discovery of animal cloning and subsequent development of cell reprogramming technology were quantum leaps as they led to the achievement of rejuvenation by cell reprogramming and the emerging view that aging is a reversible epigenetic process. Here, we will first summarize the experimental achievements over the last 7 years in cell and animal rejuvenation. Then, a comparison will be made between the principles of the cumulative DNA damage theory of aging and the basic facts underlying the epigenetic model of aging, including Horvath’s epigenetic clock. The third part will apply both models to two natural processes, namely, the setting of the aging clock in the mammalian zygote and the changes in the aging clock along successive generations in mammals. The first study demonstrating that skin fibroblasts from healthy centenarians can be rejuvenated by cell reprogramming was published in 2011 and will be discussed in some detail. Other cell rejuvenation studies in old humans and rodents published afterwards will be very briefly mentioned. The only in vivo study reporting that a number of organs of old progeric mice can be rejuvenated by cyclic partial reprogramming will also be described in some detail. The cumulative DNA damage theory of aging postulates that as an animal ages, toxic reactive oxygen species generated as byproducts of the mitochondria during respiration induce a random and progressive damage in genes thus leading cells to a progressive functional decline.
    [Show full text]
  • Measuring How Countries Adapt to Societal Aging OPINION Dana P
    OPINION Measuring how countries adapt to societal aging OPINION Dana P. Goldmana,1, Cynthia Chenb, Julie Zissimopoulosc, John W. Rowed, and the Research Network on an Aging Society Across the developed world, large increases in life expectancy over the past century, often coupled with decreasing fertility rates, have created older, top-heavy societies. The United Nations projects that by 2050 the world population of “oldest-old” aged 80 years and above will triple to 434 million (1). In the United States, this trend is personified by the baby boomer phenome- non. In 1960, only 9% of the US population was aged 65 years or older. Within a decade, that figure will double. There are now more people aged 60 years or older than those under 15 years for the first time in American history. Yet the experiences of older adults as they age are vastly different across countries. It is well established that social institutions have major positive or negative effects on the health and well-being of older persons (2). These effects are mediated through access to ef- fective health care, support to enhance function and restrict dependency, financial security, and opportuni- The experiences of older adults as they age are vastly different across countries. ties for older persons to effectively engage in society To enhance the quality of life of the elderly and allow them to effectively engage (3). Therefore, we must shift from our prior sole focus in society, we must devise strategies that ensure that each society is successfully on individuals and their immediate environments to a adapting to population aging.
    [Show full text]